您的位置: 首页 > 农业专利 > 详情页

DETERMINATION OF PATIENT BLOOD VOLUME AT START OF A DIALYSIS TREATMENT
专利权人:
Fresenius Medical Care Holdings; Inc.
发明人:
Louis LeeGrande Barrett,Perry N. Law,Douglas L. Cox
申请号:
US16207980
公开号:
US20200171229A1
申请日:
2018.12.03
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Embodiments of the disclosure provide a method for determining beginning blood volume of a patient during dialysis (e.g., hemodialysis). Ultrafiltration rates are determined at different time stamps during dialysis by obtaining a blood flowrate measurement and hematocrit measurements at input port and output port of a dialyzer connected to the patient. The flowrate and hematocrit measurements are used to determine fluid removed from the patient during dialysis. The ultrafiltration rates and fluid removed from the patient are used to determine the beginning blood volume of the patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充